Publications by authors named "Martin Summers"

Introduction: PF-06881894 is a proposed biosimilar to pegfilgrastim (Neulasta). This study evaluated the pharmacodynamic/pharmacokinetic (PD/PK) equivalence, immunogenicity, and safety of PF-06881894 vs pegfilgrastim reference products (US- and EU-Neulasta) in healthy volunteers.

Methods: A phase 1, open-label, randomized, crossover study was conducted to assess the pharmacologic equivalence and safety of a single 6-mg dose of PF-06881894, pegfilgrastim-US, and pegfilgrastim-EU.

View Article and Find Full Text PDF

Background: Three comparative clinical studies assessed the pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity and safety of PF-06881893 (filgrastim-aafi; Nivestym™), a filgrastim biosimilar, versus US-licensed reference product (filgrastim; US-Neupogen) in healthy volunteers (HVs).

Methods: Two separate open-label, crossover-design PK/PD studies were conducted: a single-dose study (n = 24) and a multiple-dose study (n = 60). In each study, HVs were randomized to Nivestym followed by US-Neupogen, or vice versa.

View Article and Find Full Text PDF

This article examines the historical parallels and convergences between ideas of racial difference in the Anglo-American psychiatric community and concrete practices of inmate management in mental institutions in the postemancipation United States and colonial sub-Saharan Africa. It maps the theories and rhetoric of racial hierarchy that characterized psychiatrists' thought regarding the etiology of mental illness among people of African descent and the specific pathologies to which they were subject. Taking a closer look at Saint Elizabeths Hospital, a federal mental institution in Washington, D.

View Article and Find Full Text PDF